Table 2 Disease activity, measured by VAS and BASDAI, and the COVID-19 severity in SpA patients
VAS 0–4 | VAS 5–10 | OR (95% CI) | P value | |||
|---|---|---|---|---|---|---|
n | % | n | % | |||
Hospitalization | 5 | 83.3 | 1 | 16.7 | 0.63 (0.06–5.82) | 0.570 |
Intensive unit care | 3 | 75.0 | 1 | 25.0 | 1.09 (0.10-11.25) | 1.000 |
BASDAI 0–4 | BASDAI 5–10 | OR (95% CI) | P value | |||
n | % | n | % | |||
Hospitalization | 2 | 66.7 | 1 | 33.3 | 1.35 (0.11–15.9) | 1.000 |
Intensive unit care | 1 | 50.0 | 1 | 50.0 | 2.76 (0.16–46.6) | 0.474 |